ArticleMolecular therapy oncolytics2021

IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma.

Miika Martikainen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.